Skip to main content
  • Home
  • Nancy A. Nickman

Nancy A. Nickman




  • Dr. Nancy Nickman is a Professor of Pharmacotherapy and Adjunct Professor of Mechanical Engineering at the University of Utah. She received a B.S. in Pharmacy (1982, University of Montana), and graduate degrees from the University of Minnesota in Hospital Pharmacy (1984, MS) and Social and Administrative Pharmacy (1987, PhD). She also completed an ASHP Residency at United and Children's Hospital (1982-1984, St. Paul, MN). Her teaching and research expertise includes patient-centered outcomes research to improve provision and quality of patient care based on application of industrial engineering and economic analyses. Publications and presentations include work sampling evaluations of institutional pharmacy services for re-design of structural and functional activities, pre-post analyses of the impact of technology on the practice of health professionals, simulated time-and-motion evaluations coupled with microcost analyses of issues related to medication preparation and administration, and analysis of devices intended for medication self-administration. Since 2012, Nancy has served as a Clinical Coordinator for Analytics and Outcomes for Pharmacy Services, University of Utah Health Care. For 2016-17, she is serving as co-Chair of the ASHP Section on Pharmacy Informatics and Technology (SOPIT) Pharmacy Operations Automation (POA) Section Advisory Group (SAG). From 2013-2016, she co-chaired the “Automation of the Pharmacy Enterprise” subgroup of the POA SAG and has been a POA member since 2010.


  • PhD Social and Administrative Pharmacy, University of Minnesota
  • MS Hospital Pharmacy, University of Minnesota
  • BS Pharmacy, University of Montana

Clinical Practice and Research Interests

  • Evaluation of Pharmacy Services
  • Pharmacoeconomics Research
  • Patient Services Evaluation

Professional Affiliations

  • American Society of Health-System Pharmacists
  • Utah Society of Health-System Pharmacists

Courses Taught

  • PCTH 6891/7891 Research Seminar
  • PHARM 5143Community Agency Practicum


    • Schmier J, Ogden K, Nickman NA, Halpern M, Cifaldi M, Ganguli A, Bao Y, Garg V. Costs of Providing Infusion Therapy for Rheumatoid Arthritis in the Hospital-Based Infusion. Clinical Therapeutics 2017
    • Aguero D, Cooley T, De la Torre C, Ferer, D, Fruidenberg P, Nickman N, Ordway B, Tjhio D, Urbanski C, Volpe G. Optimizing automation and technology across a pharmacy enterprise. Am J Health-Syst Pharm 2016; 73:1347-50.
    • Chen AL, Kim JW, Boucher K, Terakedis B, Williams BA, Nickman NA, Gaffney DK. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformational radiation therapy for postoperative treatment of gynecologic cancers. Gyn Onc 2015; 136: 521-8.
    • Nickman NA, Ye X, Gaffney DK, Barney RB, Biskupiak JE, Okano GJ, Lee VC, Arellano J. Cost of palliative external beam radiotherapy (EBRT) utilization for bone metastases secondary to prostate cancer. J Community & Supportive Oncology 2015; 13(3): 95-103..
    • Volpe G, Nickman NA, Bussard WE, Giacomelli B, Ferer DS, Urbanski C, Brookins L. Automation and improved technology to promote database synchronization. Am J Health-Syst Pharm 2014; 71:675-8.
    • Cai B, Nickman NA, Gaffney DK. The cost-effectiveness of external beam radiation therapy in bone metastases. Current Opin Support Palliat Care 2013; 7: 278-283 doi.10.1097/SPC.0b013e328362e8e3
    • Cai B, Nickman NA, Gaffney DK. The role of palliative external beam radiation therapy in boney metastases pain management. J Pain Palliat Care 2013; 27 (1): 1-7 doi.10.3109/15360288.2012.757267
    • Young, J, Nickman NA, Biskupiak JE, Barney RB, Gaffney DK, Namjoshi M, Brandt P. Characterization of clinical course and usual care patterns in female breast cancer patients treated with zoledronic acid. The Breast 2012; 22:495-503 
    • Nickman NA. Safety of automation technologies in healthcare. J Ergonom 2012; 2: e109 doi: 10.4172/2165-7556.1000e109. Editorial.
    • McAdam-Marx C, Unni S, Ye X, Nelson S, Nickman NA. Effect of medicare reimbursement reduction for imaging services on osteoporosis screening rates. J Am Geriatr Soc 2012; doi: 10.1111/j.1532-5415.2011.03837.x. [Epub ahead of print].
    • Nickman NA, Dunn JD. Issues related to recombinant human growth hormone utilization and optimization in a health plan. Am J Manage Care 2011; 17 (18 Suppl): eS11- eS 15.
    • Dunn JD, Nickman NA. Indications for recombinant human growth hormone and evaluation of available recombinant human growth hormone devices: implications for managed care organizations. Am J Manage Care 2011; 17 (18 Suppl): eS16- eS 22.
    • Nickman NA, Haak S, Kim JW. Use of clinical simulation centers in health professions schools for patient-centered research. Sim Healthcare 2010; 5: 295-302.
    • Nickman NA, Haak SW, Kim JW. Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations. BMC Nursing 2010; 9 (6): doi .
    • Nickman NA, Biskupiak J, Creekmore F, Shah H, Brixner DI. Antiplatelet medication management in patients hospitalized with ischemic stroke. Am J Health-Syst Pharm 2007; 64: 2250-6.
    • Brixner DI, Oderda GM, Nickman NA, Beveridge R, Jorgenson JA. Documentation of chemotherapy infusion preparation costs in academic and community-based oncology practices. J National Comprehensive Cancer Network 2006; 4: 197-208.